Phibro Animal Health PAHC Animal Health — Gain Loss Related To Litigation Settlement

Similar metrics at other companies

AMRXAffordable Medicines — Gain (Loss) from Litigation Settlement

-$694K—

SYYGain (Loss) Related to Litigation Settlement

$122M—

FBPGain (Loss) from Litigation Settlement

$0—

KEE

KEELGain (Loss) from Litigation Settlement

$236.25K—

MCKLitigation settlement gain (loss)

$1M—

ANDGGain (Loss) from Litigation Settlement

$2.36M—

Other financials

Income statement

See full

Revenue$383.5M+10.3%

Gross profit$125.7M+20.2%

Operating income$44.7M+33.2%

Net income$24.0M+15.1%

EPS (diluted)$0.59+15.7%

Balance sheet

See full

Cash & equivalents$54.9M-9.0%

Total debt$32.3M+27.8%

Total equity$361.8M+36.0%

Total assets$1.4B+9.7%

Cash flow

See full

Operating cash flow$16.2M-62.4%

CapEx$15.3M+97.7%

Free cash flow$890.0K-97.5%

Valuation

See full

Market cap$1.27B+33.4%

Enterprise value$1.25B+36.0%

P/E13.4×-16.6×

P/S0.9×0.0×

Profitability

See full

Gross margin32.5%+0.9pp

Operating margin12%+4.0pp

Net margin6.3%+3.7pp

FCF margin0.9%-3.3pp

Returns & leverage

See full

Return on equity30.3%+18.5pp

Debt / equity0.1×0.0×

Current ratio3.2×+0.3×

Where this comes from

Reported directly by Phibro Animal Health in its filing.

Tagged under the XBRL concept us-gaap:GainLossRelatedToLitigationSettlement.

The official record: Phibro Animal Health’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's animal health — gain loss related to litigation settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Phibro Animal Health's animal health — gain loss related to litigation settlement?: Phibro Animal Health (PAHC) reported animal health — gain loss related to litigation settlement of $1.18M in Q3 2025.
What does animal health — gain loss related to litigation settlement mean?: This represents the financial impact of legal settlements, including gains or losses arising from litigation involving the animal health segment. It reflects the volatility associated with legal risks and regulatory challenges inherent in the animal health industry. This metric is critical for assessing the impact of non-operational legal events on segment earnings.